Julián Carretero
Universitat de València(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Lung Cancer Research Studies, ATP Synthase and ATPases Research, Cancer-related gene regulation
Most-Cited Works
- → Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors(2013)1,232 cited
- → Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor(2014)451 cited
- → Inhibition of cancer growth by resveratrol is related to its low bioavailability(2002)387 cited
- → Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors(2010)260 cited
- → Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo(1999)205 cited
- → Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer(2013)202 cited
- → Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade(2017)193 cited
- → Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene(2010)191 cited
- → Intratumoral Heterogeneity in EGFR -Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition(2015)168 cited
- → Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer(2012)166 cited